Millions of people across the world benefit from weight loss drugs such as Ozempic based on the hormone GLP-1. In the new ...

The Centers for Medicare and Medicaid Services passed regulations to contain the out-of-control prior-authorization process.

Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients undergoing cancer treatments, and ...

The majority of Medicare patients opt into Medicare Advantage programs, considering them more affordable with lower premiums.

Did you know that Moringa Oleifeira, a drought-resistant tree, is equipped to fight at least three hundred different diseases ...

The University of Barcelona takes part in four research projects on neurodegenerative diseases, antimalarial drugs, minority ...

QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy business unit.

Read updates from clinical trials and scientific research on Huntington’s disease from Day 2 of the 2024 Huntington Study ...

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

On the occasion of the 100th anniversary of GZUCM, Wang Wei received an exclusive interview, explained his conception of the “best era” for the development of Chinese medicine, and how GZUCM resonates ...